Starting this fall and currently accepting enrollment, the minor will work to give students practical tools to build mental wellness while exploring the neuroscience behind different aspects of mental health.

A newly funded research project might one day lead to the development of a pill or capsule able to boost the effectiveness of traditional vaccines against influenza

In a new study, Georgia Tech researchers investigated whether 25 rare gene variants known to be associated with inflammatory bowel disease (IBD) play a role in risk for African Americans.

The senior director of the Georgia Tech Center for Mental Health Care and Resources gives tips for managing end-of-year stress.

The Georgia Tech Integrated Cancer Research Center has combined machine learning with information on blood metabolites to develop a new early diagnostic test that detects ovarian cancer with 93 percent accuracy.

Georgia Tech chemists are exploring the behavior of a complex protein associated with glaucoma — characterizing one of the largest amyloid-forming proteins to date.

The team used a computational math theory to identify gene-gene interactions that may be good targets for treating basal-like cancers that are resistant to traditional hormone therapies.

Chris Rozell traveled to Washington, D.C. to share the impacts of the past decade of brain research funded by the NIH BRAIN Initiative with Congress — and share with local representatives how Georgia Tech is playing a key role in leading the charge.

Trammell Crow Company delivers first phase of Georgia Tech district devoted to advancing sciences that improve the human condition

Exercise is good for you. To understand why, MoTrPAC scientists are creating a whole-body map of molecular responses to endurance training — finding striking “all tissue effects” in a new set of studies, featured on the May cover of the journal Nature.